Kynurenic acid in human saliva - Does it influence oral microflora?

Pharmacological Reports

Volumn 58, Issue 3, 2006, Pages 393-398

  Kuc, Damian ^a   Rahnama, Mansur ^a   Tomaszewski, Tomasz ^a   Rzeski, Wojciech ^b,c   Wejksza, Katarzyna ^c   Urbanik Sypniewska, Teresa ^c   Parada Turska, Jolanta ^a   Wielosz, Marian ^a   Turski, Waldemar A ^a,b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^c MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

Author keywords

Bacteria; Fibroblast; Human; Kynurenic acid; Saliva

Indexed keywords

KYNURENIC ACID; LIPOPOLYSACCHARIDE; SODIUM CHLORIDE;

ARTICLE; BACTERICIDAL ACTIVITY; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FIBROBLAST; GINGIVA; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MOUTH ABSCESS; MOUTH FLORA; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SALIVA; STUDENT T TEST;

EID: 33746329013     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Almstahl A, Wikstrom M, Stenberg I, Jakobsson A, Fagerberg-Mohlin B: Oral microbiota associated with hyposalivation of different origins. Oral Microbiol Immunol, 2003, 18, 1-8.
2. Baran H, Hainfellner JA, Kepplinger B, Mazal PR, Schmid H, Budka H: Kynurenic acid metabolism in the brain of HIV-1 infected patients. J Neural Transm, 2000, 107, 1127-1138.
3. Birch PJ, Grossman CJ, Hayes AG: Kynurenate and FG9041 have both competitive and non-competitive antagonist actions at excitatory amino acid receptors. Eur J Pharmacol, 1988, 151, 313-315.
4. Erhardt S, Engberg G: Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid. Acta Physiol Scand, 2002, 175, 45-53.
5. Gramsbergen JB, Hodgkins PS, Rassoulpour A, Turski WA, Guidetti P, Schwarcz R: Brain-specific modulation of kynurenic acid synthesis in the rat. J Neurochem, 1997, 69, 290-298.
6. Heyes MP, Brew BJ, Saito K, Quearry BJ, Price RW, Lee K, Bhalla RB, Der M, Markey SP: Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients. J Neuroimmunol, 1992, 40, 71-80.
7. Heyes MP, Saito K, Crowley JS, Davis LE, Demitrack MA, Der M, Dilling LA et al.: Quinolinic acid and kynurenine pathway metabolism in inflammatory and noninflammatory neurological disease. Brain, 1992, 115, 1249-1273.
8. Heyes MP, Saito K, Major EO, Milstien S, Markey SP, Vickers JH: A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate. Brain, 1993, 116, 1425-1450.
9. Hilmas C, Pereira EF, Alkondon M, Rassoulpour A, Schwarcz R, Albuquerque EX: The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J Neurosci, 2001, 21, 7463-7473.
10. Humphrey SP, Williamson RT: A review of saliva: normal composition, flow, and function. J Prosthet Dent, 2001, 85, 162-169.
11. Kazda H, Taylor N, Healy D, Walker D: Maternal, umbilical, and amniotic fluid concentrations of tryptophan and kynurenine after labor or cesarean section. Pediatr Res, 1998, 44, 368-373.
12. Kocki T, Dolinska M, Dybel A, Urbanska EM, Turski WA, Albrecht J: Regulation of kynurenic acid synthesis in C6 glioma cells. J Neurosci Res, 2002, 68, 622-626.
13. Milart P, Urbanska EM, Turski WA, Paszkowski T, Sikorski R: Intrapartum levels of endogenous glutamate antagonist - kynurenic acid in amniotic fluid, umbilical and maternal blood. Neurosci Res Commun, 1999, 24, 173-178.
14. Moroni F, Russi P, Gallo-Mezo MA, Moneti G, Pellicciari R: Modulation of quinolinic and kynurenic acid content in the rat brain: effects of endotoxins and nicotinylalanine. J Neurochem, 1991, 57, 1630-1635.
15. Moroni F, Russi P, Lombardi G, Beni M, Carla V: Presence of kynurenic acid in the mammalian brain. J Neurochem, 1988, 51, 177-180.
16. Parada-Turska J, Rzeski W, Zgrajka W, Majdan M, Kandefer-Szerszen M, Turski W: Kynurenic acid, an endogenous constituent of rheumatoid arthritis synovial fluid, inhibits proliferation of synoviocytes in vitro. Rheumatol Int, 2006, 26, 422-426.
17. Parsons CG, Danysz W, Quack G, Hartmann S, Lorenz B, Wollenburg C, Baran L et al.: Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization. J Pharmacol Exp Ther, 1997, 283, 1264-1275.
18. Perkins MN, Stone TW: An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res, 1982, 247, 184-187.
19. Rejdak R, Zarnowski T, Turski WA, Kocki T, Zagorski Z, Zrenner E, Schuettauf F: Alterations of kynurenic acid content in the retina in response to retinal ganglion cell damage. Vision Res, 2003, 43, 497-503.
20. Rzeski W, Kocki T, Dybel A, Wejksza K, Zdzisinska B, Kandefer-Szerszen M, Turski WA et al.: Demonstration of kynurenine aminotransferases I and II and characterization of kynurenic acid synthesis in cultured cerebral cortical neurons. J Neurosci Res, 2005, 80, 677-682.
21. Scharfman HE, Goodman JH, Schwarcz R: Electro-physiological effects of exogenous and endogenous kynurenic acid in the rat brain: studies in vivo and in vitro. Amino Acids, 2000, 19, 283-297.
22. Schwarcz R, Pellicciari R: Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J Pharmacol Exp Ther, 2002, 303, 1-10.
23. Stazka J, Luchowski P, Wielosz M, Kleinrok Z, Urbanska EM: Endothelium-dependent production and liberation of kynurenic acid by rat aortic rings exposed to L-kynurenine. Eur J Pharmacol, 2002, 448, 133-137.
24. Swartz KJ, Matson WR, MacGarvey U, Ryan EA, Beal MF: Measurement of kynurenic acid in mammalian brain extracts and cerebrospinal fluid by high-performance liquid chromatography with fluorometric and coulometric electrode array detection. Anal Biochem, 1990, 185, 363-376.
25. Turski WA, Gramsbergen JB, Traitler H, Schwarcz R: Rat brain slices produce and liberate kynurenic acid upon exposure to L-kynurenine. J Neurochem, 1989, 52, 1629-1636.
26. Turski WA, Nakamura M, Todd WP, Carpenter BK, Whetsell WO Jr., Schwarcz R: Identification and quantification of kynurenic acid in human brain tissue. Brain Res, 1988, 454, 164-169.
27. Wejksza K, Rzeski W, Okuno E, Kandefer-Szerszen M, Albrecht J, Turski WA: Demonstration of kynurenine aminotransferases I and II and characterization of kynurenic acid synthesis in oligodendrocyte cell line (OLN-93). Neurochem Res, 2005, 30, 963-968.
28. Wejksza K, Rzeski W, Parada-Turska J, Zdzisinska B, Rejdak R, Kocki T, Okuno E et al.: Kynurenic acid production in cultured bovine aortic endothelial cells. Homocysteine is a potent inhibitor. Naunyn Schmiedebergs Arch Pharmacol, 2004, 369, 300-304.
29. Wejksza K, Rzeski W, Turski WA, Hilgier W, Dybel A, Albrecht J: Ammonia at pathophysiologically relevant concentrations activates kynurenic acid synthesis in cultured astrocytes and neurons: Neurotoxicology, 2006, 27, 619-622.